The future of DNA technology: Munro Partners

January 4, 2019

Recent innovations in diagnostics, medical technology and genomics will allow the treatment of patients as individuals with greater accuracy – thus reducing costs, improving patient outcomes, along with preventing and curing diseases.

This could also go some way to addressing rising global costs in health care, exacerbated by the ageing population and obesity.

This rapidly developing health care innovation or “Innovative Health” is an Area of Interest for Munro Partners.

To read the article, click here.

Tags:
Categories: Insights



© Grant Samuel Funds Management 2019